U.S. Markets closed

AngioDynamics, Inc. (ANGO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.24-0.91 (-4.52%)
At close: 04:00PM EDT
19.24 0.00 (0.00%)
After hours: 05:00PM EDT

AngioDynamics, Inc.

14 Plaza Drive
Latham, NY 12110
United States
518 795 1400

IndustryMedical Instruments & Supplies
Full Time Employees800

Key Executives

NameTitlePayExercisedYear Born
Mr. James C. ClemmerCEO, Pres & Director1.91MN/A1964
Mr. Stephen A. TrowbridgeExec. VP & CFO812.99k138.16k1974
Mr. David D. HelselSr. VP of Global Operations and R&D664.29kN/A1964
Mr. Chad T. CampbellSr. VP & GM of Vascular Access Global Bus. Unit589.75kN/A1971
Mr. Warren G. NighanSr. VP of Quality & Regulatory Affairs622.11kN/A1969
Mr. Richard C. RosenzweigSr. VP, Gen. Counsel & Company Sec.N/AN/A1967
Mr. Benjamin H. DavisSr. VP of Bus. Devel.N/AN/A1964
Ms. Marna I. Bronfen-MooreSr. VP of HRN/AN/A1967
Ms. Kim L. SeaburySr. VP of Information TechnologyN/AN/A1967
Mr. Scott CenteaSr. VP & GM of Vascular Interventions and Therapies & Peripheral Artery DiseaseN/AN/A1978
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Corporate Governance

AngioDynamics, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 3. The pillar scores are Audit: 5; Board: 2; Shareholder Rights: 6; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.